Laboratory Automation Report Category

As drug discovery and research efforts for COVID-19 therapies have inherited the spotlight in pharma and clinical labs around the world, interest in automated liquid handlers and robotics that can handle the workload has been increasing rapidly. This should not be surprising, as large-scale testing is needed to process thousands of patient samples every day […]

covid-19 outbreak

The 2020 SDi Global Assessment has been updated for the first time in the publication history of the report in response to the COVID-19 Pandemic. The 2020 SDi Global Assessment Report contains insights into the impact of the COVID-19 pandemic on the global instrumentation industry. With this completely updated report and a new add-on item, the Global Quarterly Datastream, your company can leverage […]

molecular spectroscopy market

Molecular spectroscopy is made up of a diverse set of analytical techniques from room-spanning NMR instruments to photometers that can fit in your pocket. This segment of analytical instrumentation accounts for over $3 billion of the total market, and will see moderate growth over the next five years. The current situation surrounding the COVID-19 pandemic […]

second wave

As COVID-19 has spread from its origins to almost every corner of the world over the past six months, it has engendered major changes around the globe. The virus has caused a global slowdown due to lockdowns, supply chain disruptions, and reduced production levels, while also stimulating a vaccine race among pharmaceuticals and biotech companies. […]

Global Business COVID-19

The world has been justly preoccupied with the spread of COVID-19 throughout the world and its effects on human health. From a science standpoint, the life science and analytical instrumentation industry has responded to help combat the disease, by supporting research into better diagnosis, treatment, and prevention of the disease. From a business perspective, there […]

terahertz spectroscopy

While standard viral tests involving PCR are the primary way to diagnose an active COVID-19 infection, researchers are naturally pursuing alternatives that may provide other advantages. Currently, there is a focus on developing antibody tests, for instance, which could also determine whether a patient had previously been infected, helping epidemiologists better understand the spread of […]

COVID-19

As of April 2020, the COVID-19 pandemic has infected millions and killed more than one hundred thousand people, requiring lockdowns and social distancing measures that, in turn, greatly hurt the profitability of many industries. The pharmaceutical industry is no exception to the economic downturn, despite its activities being more important than ever.